Literature DB >> 33258574

The Association of Laboratory Test Abnormalities With Mortality Risk in Pediatric Intensive Care.

Murray M Pollack1, James M Chamberlain2, Anita K Patel1, Julia A Heneghan1, Eduardo A Trujillo Rivera3, Dongkyu Kim4, James E Bost4.   

Abstract

OBJECTIVES: To determine the bivariable associations between abnormalities of 28 common laboratory tests and hospital mortality and determine how mortality risks changes when the ranges are evaluated in the context of commonly used laboratory test panels.
DESIGN: A 2009-2016 cohort from the Health Facts (Cerner Corporation, Kansas City, MO) database.
SETTING: Hospitals caring for children in ICUs. PATIENTS: Children cared for in ICUs with laboratory data.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: There were 2,987,515 laboratory measurements in 71,563 children. The distribution of laboratory test values in 10 groups defined by population percentiles demonstrated the midrange of tests was within the normal range except for those measured predominantly when significant abnormalities are suspected. Logistic regression analysis at the patient level combined the population-based groups into ranges with nonoverlapping mortality odds ratios. The most deviant test ranges associated with increased mortality risk (mortality odds ratios > 5.0) included variables associated with acidosis, coagulation abnormalities and blood loss, immune function, liver function, nutritional status, and the basic metabolic profile. The test ranges most associated with survival included normal values for chloride, pH, and bicarbonate/total Co2. When the significant test ranges from bivariable analyses were combined in commonly used test panels, they generally remained significant but were reduced as risk was distributed among the tests.
CONCLUSIONS: The relative importance of laboratory test ranges vary widely, with some ranges strongly associated with mortality and others strongly associated with survival. When evaluated in the context of test panels rather than isolated tests, the mortality odds ratios for the test ranges decreased but generally remained significant as risk was distributed among the components of the test panels. These data are useful to develop critical values for children in ICUs, to identify risk factors previously underappreciated, for education and training, and for future risk score development.
Copyright © 2020 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Entities:  

Mesh:

Year:  2021        PMID: 33258574      PMCID: PMC7855885          DOI: 10.1097/PCC.0000000000002610

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.971


  31 in total

1.  Alert value reporting: a new strategy for patient safety.

Authors:  Maria Salinas; Maite López-Garrigós; Alberto Asencio; Javier Lugo; Mercedes Gutiérrez; Lucia Flors; Carlos Leiva-Salinas
Journal:  Clin Biochem       Date:  2012-11-27       Impact factor: 3.281

2.  Age Limit of Pediatrics.

Authors:  Amy Peykoff Hardin; Jesse M Hackell
Journal:  Pediatrics       Date:  2017-08-21       Impact factor: 7.124

3.  Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children.

Authors:  Travis J Matics; L Nelson Sanchez-Pinto
Journal:  JAMA Pediatr       Date:  2017-10-02       Impact factor: 16.193

Review 4.  Assessing thrombocytopenia in the intensive care unit: the past, present, and future.

Authors:  Ryan Zarychanski; Donald S Houston
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

6.  Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.

Authors:  Jack E Zimmerman; Andrew A Kramer; Douglas S McNair; Fern M Malila
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

7.  Consensus Recommendations for RBC Transfusion Practice in Critically Ill Children From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Stacey L Valentine; Melania M Bembea; Jennifer A Muszynski; Jill M Cholette; Allan Doctor; Phillip C Spinella; Marie E Steiner; Marisa Tucci; Nabil E Hassan; Robert I Parker; Jacques Lacroix; Andrew Argent; Jeffrey L Carson; Kenneth E Remy; Pierre Demaret; Guillaume Emeriaud; Martin C J Kneyber; Nina Guzzetta; Mark W Hall; Duncan Macrae; Oliver Karam; Robert T Russell; Paul A Stricker; Adam M Vogel; Robert C Tasker; Alexis F Turgeon; Steven M Schwartz; Ariane Willems; Cassandra D Josephson; Naomi L C Luban; Leslie E Lehmann; Simon J Stanworth; Nicole D Zantek; Timothy E Bunchman; Ira M Cheifetz; James D Fortenberry; Meghan Delaney; Leo van de Watering; Karen A Robinson; Sara Malone; Katherine M Steffen; Scot T Bateman
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

8.  A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample.

Authors:  Jonathan P DeShazo; Mark A Hoffman
Journal:  BMC Health Serv Res       Date:  2015-09-15       Impact factor: 2.655

9.  Customized reference ranges for laboratory values decrease false positive alerts in intensive care unit patients.

Authors:  Oguz Kilickaya; Christopher Schmickl; Adil Ahmed; Juan Pulido; James Onigkeit; Kianoush Kashani; Ognjen Gajic; Vitaly Herasevich; Brian Pickering
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

10.  Development and initial validation of the Bedside Paediatric Early Warning System score.

Authors:  Christopher S Parshuram; James Hutchison; Kristen Middaugh
Journal:  Crit Care       Date:  2009-08-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.